Regular Article
A Study of Mechanisms Underlying Amitriptyline-Induced Acute Lung Function Impairment

https://doi.org/10.1006/taap.2001.9305Get rights and content

Abstract

In this study possible mechanisms underlying the vaso- and bronchoconstriction caused by the tricyclic antidepressant drug amitriptyline in isolated rat lungs were investigated. Some features here are similar to those apparent in adult respiratory distress syndrome and acute lung injury. Amitriptyline exposure (50 and 100 μM) caused a dose-related, pronounced, and rapid vaso- (50 μM, 30 min, p< 0.001 and 100 μM, 30 min, p < 0.001) and bronchoconstriction (50 μM, 30 min, p = 0.01 and 100 μM, 30 min, p < 0.001). The maximal noted decrease in perfusion flow was 28 ± 2.9% at 25 min and 80 ± 4.5% at 30 min for 50 and 100 μM amitriptyline, respectively. The maximal noted decrease in airway conductance was 29 ± 4.7% at 25 min and 68 ± 5.0% at 30 min. To investigate mechanisms thought to be involved in amitriptyline-induced lung function impairment, lungs were treated with several different substances including antiinflammatory agents, antioxidants, inhibitors of enzymes involved in the arachidonic acid cascade, physiological antagonists, and neurogenic antagonists. A significant reduction of amitriptyline-induced vasoconstriction was observed when lungs were treated with the protein kinase inhibitor staurosporine (3 μM, 30 min, p < 0.001), the NO-donor S-nitrosoglutathione (100 μM, 30 min, p < 0.001) and the combined endothelin A/endothelin B receptor antagonist PD 145065. This latter inhibitor caused a significant attenuation of late vasoconstriction (1 μM, 60 min, p = 0.03). The amitriptyline-induced bronchoconstriction was attenuated by the β2-agonist salbutamol (1 μM, 30 min, p = 0.03) and the platelet-activating factor antagonist WEB2086 (10 μM, 30 min, p = 0.03). Staurosporine had an initial protective effect on bronchoconstriction (3 μM, 5 min, p = 0.003), while PD145065 significantly decreased bronchoconstriction 60 min after start of amitriptyline exposure (1 μM, 30 min, p = 0.003). This indicates that endothelin as well as platelet activating factor and protein kinase activation are important in mediating amitriptyline-induced lung function impairment in our experimental model and perhaps also in acute lung injury.

References (58)

  • S.B. Mustafa et al.

    Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells

    Hepatology

    (1995)
  • A.W. Obianime et al.

    The effect of smooth muscle relaxants working through different transduction mechanisms on the phorbol dibutyrate-induced contraction of the guinea-pig lung parenchymal strip: Possible relevance for asthma

    Pulm. Pharmacol.

    (1989)
  • T.M. Roy et al.

    Pulmonary complications after tricyclic antidepressant overdose

    Chest

    (1989)
  • T. Simmet et al.

    Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats

    Eur. J. Pharmacol.

    (1992)
  • T. Suhara et al.

    Lung as reservoir for antidepressants in pharmacokinetic drug interactions

    Lancet

    (1998)
  • M. Antonelli et al.

    Differential evaluation of bronchoalveolar lavage cells and leukotrienes in unilateral acute lung injury and ARDS patients

    Intensive Care Med.

    (1989)
  • G. Bannenberg et al.

    Hydrogen peroxide-induced broncho- and vasoconstriction in the isolated perfused and ventilated guinea pig lung

    Pharmacol. Toxicol.

    (1993)
  • G. Bannenberg et al.

    Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung

    J. Pharmacol. Exp. Ther.

    (1995)
  • G.R. Bernard et al.

    The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

    Am. J. Respir. Crit. Care Med.

    (1994)
  • G.R. Bernard et al.

    Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome

    Am. Rev. Respir. Dis.

    (1991)
  • M. Bhat et al.

    Regulation of tight junction permeability by calcium mediators and cell cytoskeleton in rabbit tracheal epithelium

    Pharm. Res.

    (1993)
  • K.L. Dahlin et al.

    Amitriptyline-induced release of endothelin-1 in isolated perfused and ventilated rat lungs

    Pharmacol. Toxicol.

    (1999)
  • W. Druml et al.

    Endothelin-1 in adult respiratory distress syndrome

    Am. Rev. Respir. Dis.

    (1993)
  • T.E. Eling et al.

    A study of the dynamics of imipramine accumulation in the isolated perfused rabbit lung

    Drug Metab. Dispos.

    (1975)
  • J.G. Filep et al.

    Endothelin-1-induced myocardial ischaemia and oedema in the rat: Involvement of the ETA receptor, platelet-activating factor and thromboxane A2

    Br. J. Pharmacol.

    (1994)
  • S.R. Guharoy

    Adult respiratory distress syndrome associated with amitriptyline overdose

    Vet. Hum. Toxicol.

    (1994)
  • J.E. Heffner et al.

    Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2

    J. Clin. Invest.

    (1983)
  • B.Å. Hulten et al.

    Severe amitriptyline overdose: Relationship between toxicokinetics and toxicodynamics

    J. Toxicol. Clin. Toxicol.

    (1992)
  • Cited by (9)

    • Pulmonary effects and disposition of luteolin and Artemisia afra extracts in isolated perfused lungs

      2013, Journal of Ethnopharmacology
      Citation Excerpt :

      The administration of nebulized Artemisia afra extract could thus be a better alternative to the traditionally-used steam inhalation for the treatment of respiratory conditions, provided that other factors (such as convenience, availability of nebulizer) are also considered and dealt with. In conclusion, inhalation of Artemisia afra steam and nebulized Artemisia afra extract and luteolin and intravenously-administered luteolin produced improvements in lung function similar to that obtained with known bronchodilators (Svens and Rvrfeldt, 2001). Artemisia afra extracts containing appreciable amounts of luteolin produced pulmonary effects similar in magnitude to that of luteolin, suggesting that luteolin could be an important contributor to the pulmonary effects of Artemisia afra.

    • Platelet activating factors in depression and coronary artery disease: A potential biomarker related to inflammatory mechanisms and neurodegeneration

      2013, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Furthermore, characterizing the fluctuations in the lipid profile of depressed CAD patients during antidepressant interventions may elucidate the role of PAFs and upstream precursors such as lyso-PAFs as biomarkers and/or therapeutic targets in depression and CAD. PAFs have yet to be investigated as biomarkers of depressive symptoms or interventional response in CAD; however, previous literature has described interactions between some antidepressants and PAF-mediated inflammatory and vascular modifications (Svens and Ryrfeldt, 2001; Strumper et al., 2003; Yang et al., 2010). Although the clinical association between antidepressants and PAFs has yet to be explored, we cannot rule out the possibility that PAFs interact with antidepressant response in CAD patients.

    • Vasoconstriction after inhalation of budesonide: A study in the isolated and perfused rat lung

      2010, Pulmonary Pharmacology and Therapeutics
      Citation Excerpt :

      This would indicate that noradrenergic signalling was involved in the corticosteroid-sensitive regulation of smooth muscle tone in airway vasculature [9,10]. The isolated and perfused rat lung (IPL) has been used in our laboratory as a model for studying effects of various pharmacological interventions on lung mechanics and vasoconstriction [11,12]. Recently, the DustGun aerosol technology has been used to expose the IPL, via dry powder inhalation, to aerosols of drugs and toxicants [13–15].

    View all citing articles on Scopus
    1

    To whom correspondence should be addressed. Fax: +46 8 30 33 90; E-mail: [email protected].

    View full text